Safety and Efficacy of ProHema Modulated Umbilical Cord Blood Units in Subjects With Hematologic Malignancies.

NCT00890500 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Hematologic Malignancies
Allogeneic Stem Cell Transplantation

Interventions

DRUG: Fludarabine
DRUG: Melphalan
DRUG: Antithymocyte Globulin
DRUG: Sirolimus
DRUG: Tacrolimus

Sponsor

Fate Therapeutics

Collaborators

[object Object]